VERTEX PHARMACEUTICALS INC / MA Proceeds from Common Stock Issued
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Proceeds from Common Stock Issued of $801.38 million for the 12-month period ending 2009-12-31, per its 10-K filed 2012-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2012-02-22
- VERTEX PHARMACEUTICALS INC / MA proceeds from issuance of common stock for the quarter ending 2009-12-31 was $488.13M.
- VERTEX PHARMACEUTICALS INC / MA proceeds from issuance of common stock for the quarter ending 2009-09-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA proceeds from issuance of common stock for the quarter ending 2009-06-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA proceeds from issuance of common stock for the quarter ending 2009-03-31 was $313.25M.
- VERTEX PHARMACEUTICALS INC / MA proceeds from issuance of common stock for fiscal 2009 was $801.38M, a 142.74% increase from fiscal 2008.
- VERTEX PHARMACEUTICALS INC / MA proceeds from issuance of common stock for fiscal 2008 was $330.14M.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2009-12-31 | $488.10M 10-K · filed 2012-02-22 | $488.13M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $488.13M derived: sum of 2 quarters · filed 2012-02-22 | $488.13M derived: sum of 3 quarters · filed 2012-02-22 | $801.38M 10-K · filed 2012-02-22 |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $0.00 derived: sum of 2 quarters · filed 2010-10-28 | $313.25M 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | $313.25M 10-Q · filed 2010-08-03 | |||
| 2009-03-31 | $313.25M 10-Q · filed 2010-05-03 | ||||
| 2009-02-28 | $313.30M 10-K · filed 2012-02-22 | ||||
| 2008-12-31 | $330.14M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |